OmniAb, Inc.
General ticker "OABI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $237.2M (TTM average)
OmniAb, Inc. follows the US Stock Market performance with the rate: 44.5%.
Estimated limits based on current volatility of 4.4%: low 4.05$, high 4.42$
Factors to consider:
- Total employees count: 89 (-21.9%) as of 2025
- Top business risk factors: Partner milestones missed, Partner dependency, Operational and conduct risks, Fluctuating operating results, Technology license loss
- Current price 26.2% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.27$, 3.45$]
- 2026-12-31 to 2027-12-31 estimated range: [1.44$, 3.74$]
Financial Metrics affecting the OABI estimates:
- Positive: with PPE of -3.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: Interest expense per share per price, % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 2.95 > 2.08
- Positive: Inventory ratio change, % of -6.35 <= -3.92
Short-term OABI quotes
Long-term OABI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $33.97MM | $26.39MM | $18.67MM |
| Operating Expenses | $103.39MM | $100.89MM | $87.64MM |
| Operating Income | $-69.42MM | $-74.50MM | $-68.97MM |
| Non-Operating Income | $5.06MM | $3.09MM | $2.67MM |
| R&D Expense | $56.52MM | $55.11MM | $47.75MM |
| Income(Loss) | $-64.36MM | $-71.41MM | $-66.29MM |
| Taxes | $-13.74MM | $-9.38MM | $-1.51MM |
| Net Income(Loss)* | $-50.62MM | $-62.03MM | $-64.78MM |
| Stockholders Equity | $314.58MM | $287.62MM | $267.03MM |
| Assets | $375.23MM | $325.56MM | $300.91MM |
| Operating Cash Flow | $2.35MM | $-39.66MM | $-36.45MM |
| Capital expenditure | $1.64MM | $1.88MM | $0.56MM |
| Investing Cash Flow | $-18.38MM | $37.88MM | $6.47MM |
| Financing Cash Flow | $-0.89MM | $13.02MM | $27.91MM |
| Earnings Per Share** | $-0.51 | $-0.61 | $-0.57 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.